FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Related Tags >> Biogen Idec   Elan   multiple sclerosis   FDA
Syndicate content

Tysabri News

Most Popular Tysabri Story

Biogen Idec in play after Icahn makes his move

Biotech powerhouse Biogen Idec has brought in some of Wall Streets top dealmakers to explore a possible sale of the company, which would fetch well over $20 billion. In fact, says Biogen Idec, the... Read more...

Latest Headlines